全文获取类型
| 收费全文 | 243602篇 |
| 免费 | 9472篇 |
| 国内免费 | 536篇 |
专业分类
| 耳鼻咽喉 | 3265篇 |
| 儿科学 | 8739篇 |
| 妇产科学 | 7047篇 |
| 基础医学 | 32402篇 |
| 口腔科学 | 6934篇 |
| 临床医学 | 21135篇 |
| 内科学 | 44088篇 |
| 皮肤病学 | 5193篇 |
| 神经病学 | 16177篇 |
| 特种医学 | 12521篇 |
| 外国民族医学 | 154篇 |
| 外科学 | 35726篇 |
| 综合类 | 2270篇 |
| 一般理论 | 48篇 |
| 预防医学 | 21797篇 |
| 眼科学 | 5528篇 |
| 药学 | 17072篇 |
| 2篇 | |
| 中国医学 | 165篇 |
| 肿瘤学 | 13347篇 |
出版年
| 2018年 | 4215篇 |
| 2017年 | 4429篇 |
| 2016年 | 3763篇 |
| 2015年 | 5505篇 |
| 2014年 | 5258篇 |
| 2013年 | 4950篇 |
| 2012年 | 11894篇 |
| 2011年 | 6791篇 |
| 2010年 | 3446篇 |
| 2009年 | 4952篇 |
| 2008年 | 4074篇 |
| 2007年 | 4792篇 |
| 2006年 | 5088篇 |
| 2005年 | 13134篇 |
| 2004年 | 14668篇 |
| 2003年 | 10032篇 |
| 2002年 | 5212篇 |
| 2001年 | 5943篇 |
| 2000年 | 3443篇 |
| 1999年 | 7335篇 |
| 1998年 | 1164篇 |
| 1995年 | 908篇 |
| 1992年 | 8062篇 |
| 1991年 | 8316篇 |
| 1990年 | 8467篇 |
| 1989年 | 8034篇 |
| 1988年 | 7585篇 |
| 1987年 | 7186篇 |
| 1986年 | 6898篇 |
| 1985年 | 6151篇 |
| 1984年 | 4367篇 |
| 1983年 | 3590篇 |
| 1982年 | 1458篇 |
| 1981年 | 1182篇 |
| 1980年 | 1250篇 |
| 1979年 | 4565篇 |
| 1978年 | 2943篇 |
| 1977年 | 2282篇 |
| 1976年 | 2056篇 |
| 1975年 | 2921篇 |
| 1974年 | 3604篇 |
| 1973年 | 3235篇 |
| 1972年 | 3176篇 |
| 1971年 | 3142篇 |
| 1970年 | 2925篇 |
| 1969年 | 2809篇 |
| 1968年 | 2617篇 |
| 1967年 | 2481篇 |
| 1966年 | 2215篇 |
| 1965年 | 1280篇 |
排序方式： 共有10000条查询结果，搜索用时 15 毫秒
1.
Heather L. Brown 《Journal of emergency nursing》2021,47(2):321-325
The coronavirus 2019 pandemic has affected almost every aspect of health care delivery in the United States, and the emergency medicine system has been hit particularly hard while dealing with this public health crisis. In an unprecedented time in our history, medical systems and clinicians have been asked to be creative, flexible, and innovative, all while continuing to uphold the important standards in the US health care system. To continue providing quality services to patients during this extraordinary time, care providers, organizations, administrators, and insurers have needed to alter longstanding models and procedures to respond to the dynamics of a pandemic. The Emergency Medicine Treatment and Active Labor Act of 1986, or EMTALA, is 1 example of where these alterations have allowed health care facilities and clinicians to continue their work of caring for patients while protecting both the patients and the clinicians themselves from infectious exposures at the same time. 相似文献
2.
3.
4.
Osric A. Forrest Daniel M. Chopyk Yael Gernez Milton R. Brown Carol K. Conrad Richard B. Moss Vin Tangpricha Limin Peng Rabindra Tirouvanziam 《Journal of cystic fibrosis》2019,18(1):64-70
Background
Resistin is an immunometabolic mediator that is elevated in several inflammatory disorders. A ligand for Toll-like receptor 4, resistin modulates the recruitment and activation of myeloid cells, notably neutrophils. Neutrophils are major drivers of cystic fibrosis (CF) lung disease, in part due to the release of human neutrophil elastase- and myeloperoxidase-rich primary granules, leading to tissue damage. Here we assessed the relationship of resistin to CF lung disease.Methods
Resistin levels were measured in plasma and sputum from three retrospective CF cohorts spanning a wide range of disease. We also assessed the ability of neutrophils to secrete resistin upon activation in vitro. Finally, we constructed a multivariate model assessing the relationship between resistin levels and lung function.Results
Plasma resistin levels were only marginally higher in CF than in healthy control subjects. By contrast, sputum resistin levels were very high in CF, reaching 50–100 fold higher levels than in plasma. Among CF patients, higher plasma resistin levels were associated with allergic bronchopulmonary aspergillosis, and higher sputum resistin levels were associated with CF-related diabetes. Mechanistically, in vitro release of neutrophil primary granules was concomitant with resistin secretion. Overall, sputum resistin levels were negatively correlated with CF lung function, independently of other variables (age, sex, and genotype).Conclusions
Our data establish relationships between resistin levels in the plasma and sputum of CF patients that correlate with disease status, and identify resistin as a novel mechanistic link between neutrophilic inflammation and lung disease in CF. 相似文献5.
6.
7.
8.
Dan Azagury Tara E Mokhtari Luis Garcia Ulysses S Rosas Trit Garg Homero Rivas John Morton 《Surgery》2019,165(3):565-570
Background
Laparoscopic Roux-en-Y gastric bypass, laparoscopic sleeve gastrectomy, and laparoscopic adjustable gastric banding all lead to substantial weight loss in obese patients. Long-term weight loss can be highly variable beyond 1-year postsurgery. This study examines and compares the frequency distribution of weight loss and lack of treatment effect rates after laparoscopic Roux-en-Y gastric bypass, laparoscopic sleeve gastrectomy, and laparoscopic adjustable gastric banding.Methods
A total of 1,331 consecutive patients at a single academic institution were reviewed from a prospectively collected database. Preoperative data collected included demographics, body mass index, and percent excess weight loss. Postoperative BMI and %EWL were collected at 12, 24, and 36 months. Percent excess weight loss was analyzed by the percentiles of excess weight lost, and the distribution of percent excess weight loss was evaluated in 10% increments. Lack of a successful treatment effect was defined as <25% excess weight loss.Results
Of the 1,331 patients, 72.4% (963) underwent laparoscopic Roux-en-Y gastric bypass, 18.3% (243) laparoscopic sleeve gastrectomy, and 9.4%(125) laparoscopic adjustable gastric banding. Mean percent excess weight loss was greatest for laparoscopic Roux-en-Y gastric bypass, followed by laparoscopic sleeve gastrectomy, and then by laparoscopic adjustable gastric banding at every time point: at 2 years mean percent excess weight loss was 77.9± 24.4 for laparoscopic Roux-en-Y gastric bypass, 50.8 ± 25.8 for laparoscopic sleeve gastrectomy, and 40.8± 25.9 for laparoscopic adjustable gastric banding (P < .0001). The rates of a successful treatment effect s for laparoscopic Roux-en-Y gastric bypass, laparoscopic sleeve gastrectomy, and laparoscopic adjustable gastric banding were 0.9%, 5.2%, and 24.3% at 1 year; 0.3%, 11.1%, and 26.0% at 2 years; and 1.0%, 25.3%, and 30.2% at 3 years. At 1 year, the odds ratio of lack of a successful treatment effect of laparoscopic sleeve gastrectomy versus laparoscopic Roux-en-Y gastric bypass was 6.305 (2.125–19.08; P?=?.0004), the odds ratio for laparoscopic adjustable gastric banding versus laparoscopic Roux-en-Y gastric bypass was 36.552 (15.64–95.71; P < .0001), and the odds ratio for laparoscopic adjustable gastric banding versus laparoscopic sleeve gastrectomy was 5.791 (2.519–14.599; P < .0001). At 2 years, the odds ratio for laparoscopic sleeve gastrectomy versus laparoscopic Roux-en-Y gastric bypass increased to 70.7 (9.4–531.7; P < .0001), the odds ratio for laparoscopic adjustable gastric banding versus laparoscopic Roux-en-Y gastric bypass increased to 128.1 (16.8–974.3; P < .0001), and the odds ratio for laparoscopic adjustable gastric banding versus laparoscopic sleeve gastrectomy decreased to 1.8 (0.9–3.6; P?=?.09).Conclusion
This study emphasizes the existing variability in weight loss across bariatric procedures as well as in the lack of a treatment effect for each procedure. Although laparoscopic adjustable gastric banding has the greatest rate of a lack of a successful treatment effect, the rate remained stable over 3 years postoperatively. Laparoscopic sleeve gastrectomy showed a doubling in the rate of a lack of a successful treatment effect every year reaching 25% at year 3. The rates for lack of a successful treatment effect for laparoscopic Roux-en-Y gastric bypass remained stable at about 1% for the first 3 years postoperatively. 相似文献9.
Characteristics of hyperparathyroid states in the Canadian multicentre osteoporosis study (CaMos) and relationship to skeletal markers 
下载免费PDF全文
下载免费PDF全文